BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ThermoDox heat-activated liposome: Phase III ongoing

A DMC recommended continuation of the Phase III HEAT trial based on a review of safety data from 482 patients. The double-blind, sham-controlled, international trial is comparing 50 mg/m 2 IV ThermoDox plus radiofrequency ablation vs. radiofrequency ablation alone in 600 liver cancer patients. The DMC previously recommended...

Read the full 218 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >